Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, and PARP inhibition in cancer therapy.
A Specific Methylation Class Identifies BAP1‐Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid Histology
Pulmonary vascular phenotype identified in patients with<i>GDF2</i>(<i>BMP9</i>) or<i>BMP10</i>variants: an international multicentre study
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variants
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations
HAL (Le Centre pour la Communication Scientifique Directe) 2021cited by 0position: last
Mechanisms and therapeutic implications of hypermutation in gliomas
Association of Human iPSC Gene Signatures and X Chromosome Dosage with Two Distinct Cardiac Differentiation Trajectories
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases
Genetic counselling in a national referral centre for pulmonary hypertension
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants